About Incor Medipharma Private Limited
Data last updated:
Incor Medipharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 30 September 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2022PTC167162.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pavani Tirunagari and Venkatarama Reddy Tamlampudi.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.98 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹14.21 Lakh (net margin -35.5%) and EBITDA of -₹14.08 Lakh (EBITDA margin -35.2%).
The company has about 15 employees on its provident fund (EPFO) records.
For more details, the company can be reached via its website incor.in.
Company details
Contact details
Incor Medipharma Private Limited's registered office is in Hyderabad, Telangana.
- Social Media
- Registered AddressGround Floor Vijetha Midas Touch Apts Sy No 6, White Field Road Kondapur, Hyderabad, Telangana, India – 500084
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Incor Medipharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Incor Medipharma Private Limited, buy the company report.
Financials of Incor Medipharma Private Limited
FY 2025 filings availableIncor Medipharma Private Limited reported revenue of ₹39.98 Lakh (up 1470% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹14.08 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹14.21 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -35.2% | ||
| Net Profit Margin | -35.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Incor Medipharma Private Limited, buy the company report.
Board of directors of Incor Medipharma Private Limited
Incor Medipharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pavani Tirunagari Also directs: Signam Series1 LLP, Signature Series2 LLP, Incor Mall Development Private Limited and 5 more | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
| Venkatarama Reddy Tamlampudi Also directs: Abbus Construction Private Limited, Incor Real Ventures Private Limited, Incor Hospitals Vizag Private Limited and 1 more | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
Peer comparison
Incor Medipharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shree Path Labs Private Limited | ₹40.35 Lakh (FY 2024) | -30.0% | Ajmer, Rajasthan, India | |||
| Panacea Medinfra Private Limited | ₹40.28 Lakh (FY 2025) | Ranchi, Jharkhand, India | ||||
| Aplpath Labs Private Limited | ₹40.26 Lakh (FY 2025) | 1048.0% | New Delhi, Delhi, India | |||
| Saffrokem Science Private Limited | ₹40.09 Lakh (FY 2025) | 119.0% | Bhilwara, Rajasthan, India | |||
| Sahayog Healthcare and Research Institute Private Limited | ₹40.08 Lakh (FY 2024) | 126.0% | Gondiya, Maharashtra, India | |||
| Incor Medipharma Private Limitedthis company | ₹39.98 Lakh (FY 2025) | -₹14.21 Lakh | -35.5% | 1470.0% | Hyderabad, Telangana, India | |
| Fitride Labs Private Limited | ₹39.96 Lakh (FY 2025) | -48.0% | Hyderabad, Telangana, India | |||
| Maheshwaram Hospital & Resarch Private Limited | ₹39.93 Lakh (FY 2025) | 10.0% | Jaipur, Rajasthan, India | |||
| Ag-Nee Ayurveda Private Limited | ₹39.87 Lakh (FY 2024) | 1377.0% | Noida, Uttar Pradesh, India | |||
| Shubhshiwa Health Care Foundation | ₹39.86 Lakh (FY 2025) | 61.0% | Patna, Bihar, India | |||
| Gulati Hospitals Pvt Ltd | ₹39.83 Lakh (FY 2025) | 2.0% | Haryana, India |
To see the full peer comparison of Incor Medipharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Incor Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Incor Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Incor Medipharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Incor Medipharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Pavani Tirunagari was appointed as Director on 30 Sep 2022.
News
Frequently asked questions
Incor Medipharma is an active private limited company based in Hyderabad, Telangana, India. The company works in human health activities, within the healthcare industry. It was incorporated on 30 September 2022 (4+ years old) and is registered under CIN U85100TG2022PTC167162.
Incor Medipharma has 2 current directors:
- Pavani Tirunagari - Director
- Venkatarama Reddy Tamlampudi - Director
The latest financial statements of Incor Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Incor Medipharma is U85100TG2022PTC167162. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Incor Medipharma was incorporated on 30 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Incor Medipharma by revenue are Shree Path Labs Private Limited, Panacea Medinfra Private Limited, Aplpath Labs Private Limited, Saffrokem Science Private Limited, Sahayog Healthcare and Research Institute Private Limited and 5 more, all in the same principal business activity (human health activities).
Pavani Tirunagari was appointed as Director on 30 Sep 2022. Venkatarama Reddy Tamlampudi was appointed as Director on 30 Sep 2022.
Incor Medipharma can be reached through the website incor.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Incor Medipharma is at Ground Floor Vijetha Midas Touch Apts Sy No 6, White Field Road Kondapur, Hyderabad, Telangana, India – 500084.
Incor Medipharma operates in the healthcare industry, in the human health activities segment.
Incor Medipharma is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.